Elliot Israel

Active 1984–2025

Also published as
ELLIOT ISRAEL
199
Papers
35,759
Citations
105
h-index
192
i10-index

Citations

Citations per year for Elliot Israel1952: 1 citations1979: 1 citations1984: 1 citations1985: 1 citations1986: 4 citations1987: 2 citations1988: 3 citations1989: 1 citations1990: 5 citations1991: 6 citations1992: 11 citations1993: 14 citations1994: 8 citations1995: 19 citations1996: 59 citations1997: 41 citations1998: 57 citations1999: 67 citations2000: 86 citations2001: 122 citations2002: 126 citations2003: 133 citations2004: 139 citations2005: 139 citations2006: 135 citations2007: 147 citations2008: 127 citations2009: 146 citations2010: 151 citations2011: 205 citations2012: 305 citations2013: 253 citations2014: 302 citations2015: 281 citations2016: 268 citations2017: 328 citations2018: 284 citations2019: 1,068 citations2020: 1,171 citations2021: 1,189 citations2022: 1,139 citations2023: 799 citations2024: 1,232 citations2025: 750 citations2026: 13 citations1953–1978: no citations, so these years are not shown1980–1983: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,468 citing papers, 26.8% of this breakdownUnited Kingdom: 1,244 citing papers, 9.6% of this breakdownChina: 801 citing papers, 6.2% of this breakdownItaly: 617 citing papers, 4.7% of this breakdownGermany: 531 citing papers, 4.1% of this breakdownCanada: 514 citing papers, 4% of this breakdownFrance: 465 citing papers, 3.6% of this breakdownAustralia: 430 citing papers, 3.3% of this breakdownJapan: 425 citing papers, 3.3% of this breakdownNetherlands: 413 citing papers, 3.2% of this breakdownSpain: 336 citing papers, 2.6% of this breakdownSweden: 336 citing papers, 2.6% of this breakdown
0%26.8%Other 26%

Fields

  • Medicine67%
  • Biochemistry, Genetics and Molecular Biology11.9%
  • Immunology and Microbiology11.4%
  • Nursing2%
  • Neuroscience1.7%
  • Environmental Science1.1%
  • Other4.9%

Topics

  • Asthma and respiratory diseases19.7%
  • IL-33, ST2, and ILC Pathways5.2%
  • Respiratory and Cough-Related Research5.1%
  • Chronic Obstructive Pulmonary Disease (COPD) Research4.6%
  • Allergic Rhinitis and Sensitization3.1%
  • Inhalation and Respiratory Drug Delivery3%
  • Other59.3%

Coauthors

All papers

Open in search
  1. Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma

    Authors: , , , , , , , , , , , , , - New England Journal of Medicine 2021 cited by 967

  2. Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma

    Authors: , , , , , , , , , , , , , , , - New England Journal of Medicine 2021 cited by 402

  3. Mucus plugs in patients with asthma linked to eosinophilia and airflow obstruction

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2018 cited by 598

  4. Unjamming and cell shape in the asthmatic airway epithelium

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Materials 2015 cited by 723

  5. Astegolimab (anti-ST2) efficacy and safety in adults with severe asthma: A randomized clinical trial

    Authors: , , , , , , , , , , , , , , - Journal of Allergy and Clinical Immunology 2021 cited by 306

  6. Efficacy of Tezepelumab in Severe, Uncontrolled Asthma: Pooled Analysis of the PATHWAY and NAVIGATOR Clinical Trials

    Authors: , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2023 cited by 160

  7. Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research Program

    Authors: , , , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2009 cited by 2,124

  8. Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bonavuth Pek, Guy Chouinard, Amarjit Cheema, William H. Yang, George Philteos, Pascal Chanez, Arnaud Bourdin, Gilles Devouassoux, Camille Taillé, Frédéric de Blay, Christophe Leroyer, Antoine Beurnier, Gilles Garcia, Pierre‐Olivier Girodet, F.–X. Blanc, A. Magnan, Stéphanie Wanin, J. Just, R. Linde, Stefan Zielen, Karin Förster, Christian Geßner, Margret Jandl, Roland Buhl, Stephanie Korn, Marc Oliver Kornmann, Anneliese Linnhoff, Andrea Ludwig-Sengpiel, Martin Ehlers, Tibor Schmoller, Heiner Steffen, Martin Hoffmann, J Kirschner, Olaf Schmidt, Tobias Welte, Hilke Temme, Ori Wand, Amir Bar‐Shai, Gabriel Izbicki, Neville Berkman, Gershon Fink, David Shitrit, Yochai Adir, Piotr Kuna, Barbara Rewerska, Ewa Pisarczyk-Bogacka, О М Курбачева, Sergey L Mikhailov, M.P. Vasilev, Alexander Emelyanov, Siraj Wali, Amr S. Albanna, Richard N. van Zyl-Smit, Ismail Abdullah, Ismail Abdullah, David Bernhardi, Farzana Hoosen, Elvis M. Irusen, Ismail Kalla, Deepak Lakha, Essack Mitha, Visvakuren Naidoo, Haylene Nell, Trevenesan Padayachee, Jeevren Reddy, Friedrich Petrick, Eugene van der Walt, Zubar Fazal Ahmed Vawda, Hae‐Sim Park, Sang Haak Lee and 88 more - The Lancet Respiratory Medicine 2023 cited by 141

  9. Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts

    Authors: , , , , , , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2016 cited by 535

  10. Interleukin-17–producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity

    Authors: , , , , , , , , , , , - Nature Medicine 2013 cited by 630

  11. Extracellular DNA, Neutrophil Extracellular Traps, and Inflammasome Activation in Severe Asthma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2019 cited by 269

  12. Neutrophil cytoplasts induce T H 17 differentiation and skew inflammation toward neutrophilia in severe asthma

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Science Immunology 2018 cited by 238

  13. Mucus Plugs Persist in Asthma, and Changes in Mucus Plugs Associate with Changes in Airflow over Time

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2022 cited by 141

  14. Features of the bronchial bacterial microbiome associated with atopy, asthma, and responsiveness to inhaled corticosteroid treatment

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Allergy and Clinical Immunology 2016 cited by 308

  15. Inflammatory and Comorbid Features of Patients with Severe Asthma and Frequent Exacerbations

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ross Myers, Maria Theresa D. Opina, Michael C. Peters, Mark L. Schiebler, Ronald L. Sorkness, W. Gerald Teague, Sally E. Wenzel, Prescott G. Woodruff, David T. Mauger, John V. Fahy, Nizar N. Jarjour - American Journal of Respiratory and Critical Care Medicine 2016 cited by 444

  16. CCL5 is a potential bridge between type 1 and type 2 inflammation in asthma

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Journal of Allergy and Clinical Immunology 2023 cited by 61

  17. A functional splice variant associated with decreased asthma risk abolishes the ability of gasdermin B to induce epithelial cell pyroptosis

    Authors: , , , , , , , , , , , , , , , , - Journal of Allergy and Clinical Immunology 2018 cited by 204

  18. Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATOR

    Authors: , , , , , , , , , , , , , - Journal of Asthma and Allergy 2023 cited by 65

  19. Thymic stromal lymphopoietin controls prostaglandin D2 generation in patients with aspirin-exacerbated respiratory disease

    Authors: , , , , , , , , , , - Journal of Allergy and Clinical Immunology 2015 cited by 184

  20. Genetic analyses identify GSDMB associated with asthma severity, exacerbations, and antiviral pathways

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Allergy and Clinical Immunology 2020 cited by 93

  21. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Journal of Allergy and Clinical Immunology 2007 cited by 933

  22. Severe and Difficult-to-Treat Asthma in Adults

    Authors: , - New England Journal of Medicine 2017 cited by 471

  23. Evidence for Exacerbation-Prone Asthma and Predictive Biomarkers of Exacerbation Frequency

    Authors: , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2020 cited by 166

  24. Refractory airway type 2 inflammation in a large subgroup of asthmatic patients treated with inhaled corticosteroids

    Authors: , , , , , , , , , , , , , , , , , , - Journal of Allergy and Clinical Immunology 2018 cited by 187